Farmak JSC has resumed production of the drug L-Thyroxine-Farmak

Farmak International participated in the international pharmaceutical exhibition CPHI Milan 2026, where, over the course of three days, it showcased its developments in the field of complex generics and injectable products. At CPHI Milan 2026, the Farmak International team held a series of meetings with existing and potential partners from various countries....

Farmak’s entry, centered on the company’s 100th anniversary and the creation of the corporate film *Resilient Compound* (*Stiyka Spoluka*), won the “Best Internal PR” category at the MMR PR Case Competition 2026. The results were announced on September 25 during the Total PR Marathon 2026—a professional event bringing together members of the Ukra...

Farmak has expanded its portfolio with a new product, Panjest® Lactase. The dietary supplement is recommended for consumption with lactose-containing foods as an additional source of enzymes for people who have difficulty digesting lactose. Difficulty digesting lactose is common worldwide. According to NIDDK*, approximately 68% of the world’s population has ...